Journals / Türk Üroloji Dergisi/Turkish Journal of Urology / 2013 / Cilt: 39 - Sayı: 3

Ureterocutaneostomy: for whom and when?

Üreterokutanostomi: Kime ve ne zaman?

Pages
143–146
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: UCN can be used as the method of urinary diversion in selected patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To report and discuss the indications and the results of patients treated with ureterocutaneostomy (UCN) for urinary diversion in our center.
📊
Key Findings & Data:Material and methods: Between March 2008 and November 2012, 27 patients (19 males and 8 females) were treated with UCN.
💡
Conclusion & Impact:Conclusion: UCN can be used as the method of urinary diversion in selected patients.
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To report and discuss the indications and the results of patients treated with ureterocutaneostomy (UCN) for urinary diversion in our center. Material and methods: Between March 2008 and November 2012, 27 patients (19 males and 8 females) were treated with UCN. Patient age ranged from 56-78 years. Radical cystectomy was performed on 21 of these patients. The patients underwent transureteroureterostomy and UCN or unilateral or bilateral side- by-side UCN on the abdominal wall. Double-J stents were placed inside the ureters and changed every 12 weeks. Comorbidities and American Society of Anesthesiologists (ASA) scores were noted. Results: Twenty-four patients presented with invasive bladder cancer, 1 patient with multiple tumors in and out of a diverticulum and recurrent hemorrhage, 1 patient with recurrent hemorrhage and 1 patient with bladder contracture. As comorbidities, 14 patients had hypertension, 11 patients had chronic obstructive pulmonary disease, 10 patients had diabetes mellitus, 8 patients had coronary artery disease, and 2 patients had chronic renal failure. One patient had Crohn’s disease. The ASA score was 3 or greater in 14 patients. At follow-up, 3 patients experienced pyelonephritis, and 1 had a strictured ureteral orifice. Conclusion: UCN can be used as the method of urinary diversion in selected patients.

Özet

Amaç: Çeşitli nedenlerle üriner diversiyon yöntemi olarak üretrokutaneostomi (ÜKN) seçilen olgularımız- da bunun gerekçelerini ve sonuçlarını tartışmak. Gereç ve yöntemler: Kliniğimizde Mart 2008 ile Kasım 2012 tarihleri arasında yaşları 56-78 olan 19’u erkek, 8’i kadın olmak üzere toplam 27 hastaya ÜKN uygulanmıştır. Hastalardan 21 tanesine radikal sistektomi uygulanabilmiştir. İşlem karın yan duvarına transüreteroüreterostomi ve ÜKN veya tek ya da her iki üreter yan yana ÜKN şeklinde yapıldı. İçlerine double J stent konuldu ve her on iki haftada bir değiştirildi. Hastalara eşlik eden ek hastalıkları ve ASA skorları not edildi. Bulgular: Yirmi dört hastada invaziv mesane tümörü, 1 hastada divertikül içi ve dışı yaygın tümörler ve önlenemeyen rekürren hemoraji, 1 hastada rekürren hemoraji, 1 hastada da mesane kontraktürü mevcut idi. Eşlik eden ek hastalık olarak 14 hastada hipertansiyon, 11 hastada kronik obstrüktif akciğer hastalığı, 10 hastada diabetes mellitus, 8 hastada koroner arter hastalığı ve 2 hastada kronik böbrek yetmezliği vardı. Bir hastada Crohn Hastalığı mevcut idi. Preoperatif olarak 14 hastada ASA skoru 3 ve üzerinde tespit edildi. Takiplerde 3 hastada pyelonefrit atağı gelişti, 1 hastada üreter ağzında darlık izlendi. Sonuç: Üretrokutaneostomi, iyi seçilmiş hastalarda tercih edilebilecek bir üriner diversiyon yöntemidir.

🔖

Cite This Article

KOZACIOĞLU, Z., DEĞİRMENCİ, T., GÜNLÜSOY, B., CEYLAN, Y., MİNARECİ, S. (2013). Ureterocutaneostomy: for whom and when?. Türk Üroloji Dergisi/Turkish Journal of Urology, Cilt: 39 - Sayı: 3, 143–146. https://ajindex.com/articles/328045

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30
  2. Babjuk M, Oosterlick W, Sylvester R, Kaasinen E, Böhle A, Pa- ula-Redorta J, et al. EAU Guidelines on Non-Muscle Invasive Urothelial Carcinoma of the Bladder, the 2011 Update. Eur Urol 2011;59:997-1008. [CrossRef] 3. Khosravi-Shahi P, Cabezon-Gutierrez L. Selective organ preserva- tion in muscle-invasive bladder cancer: Review of the literature. Surg Oncol 2012;21:17-22. [CrossRef] 4. Hautmann RE, Abol-Enien H, Hafez K, Haro I, Mansson W, Mills RD, et al. Urinary Diversion, WHO Consensus Conference on Bladder Cancer. Urology 2007;69:17-49. [CrossRef] 5. Vladya A, Soloway MS, Hawke C, Tiguert R, Civantos F. De novo muscle invasive bladder cancer: Is there a change in trend? J Urol 2001;165:47-50. [CrossRef] 6. Simon J. Ectopia vesicae (absence of the anterior walls of the blad- der and pubis abdominal parietis); operationfor directing the orifi- ces of the ureters into the rectum; temporary success; subsequent death; autopsy. Lancet 1852;ii:568. [CrossRef] 7. Bricker EM. Bladder substitution after pelvic evisceration. Surg Clin North Am 1950;30:1511-3
  3. Stenzl A, Cowan CN, de Santis M, Kuczyk MA, Merseburger AS, Ribal MJ, et al. Treatment of muscle invasive bladder cancer: Upda- te of the EAU Guidelines. Eur Urol 2011;59:1009-18. [CrossRef] 9. Pycha A, Comploj E, Martini T, Trenti E, Mian C, Lusuardi L, et al. Comparison of complications in three incontinent urinary diver- sions. Eur Urol 2008;54:825-32. [CrossRef] 10. Nieuwenhuijzen JA, de Vries RR, Bex A, van der Poel HG, Mein- hardt W, Antonini N, et al. Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions. Eur Urol 2008;53:834-44. [CrossRef] 11. Stenzl A, Nagele U, Kuczyk M, Sievert KD, Anastasiadis A, Se- ibold J, et al. Cystectomy- technical considerations in male and female patients. EAU Update Series 2005;3:138-46. [CrossRef] 12. Stenzl A, Colleselli K, Poisel S, Feichtinger H, Pontasch H, Bartsch G. Rationale and technique of nevre sparing radical cystectomy before an orthotopic neobladder procedure in women. J Urol 1995;154:2044-9. [CrossRef] 13. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Adjuvant chemotherapy in invasive bladder cancer: a systema- tic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol 2005;48:189-201. [CrossRef] 14